X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6) 6
index medicus (6) 6
animals (5) 5
female (5) 5
mice (5) 5
care and treatment (4) 4
genetic aspects (4) 4
oncology (4) 4
tumors (4) 4
cancer therapies (3) 3
cell line, tumor (3) 3
colorectal cancer (3) 3
health aspects (3) 3
antineoplastic agents - pharmacology (2) 2
article (2) 2
biochemistry & molecular biology (2) 2
c-met (2) 2
cancer (2) 2
cancer research (2) 2
chemotherapy (2) 2
colorectal neoplasms - drug therapy (2) 2
colorectal neoplasms - genetics (2) 2
colorectal neoplasms - metabolism (2) 2
drug resistance, neoplasm - drug effects (2) 2
drug resistance, neoplasm - genetics (2) 2
gene copy number (2) 2
gene mutations (2) 2
genetics (2) 2
medical research (2) 2
molecular targeted therapy (2) 2
mutation (2) 2
proto-oncogene proteins c-met - metabolism (2) 2
proto-oncogene proteins p21 - genetics (2) 2
receptor, erbb-2 - genetics (2) 2
research (2) 2
xenograft model antitumor assays (2) 2
xenografts (2) 2
acquired-resistance (1) 1
activating mutations (1) 1
adenocarcinoma - genetics (1) 1
adenocarcinoma - metabolism (1) 1
adult (1) 1
aged (1) 1
alpha-6-beta-4 (1) 1
analysis (1) 1
anchorage-independent growth (1) 1
animal models (1) 1
animals; antibodies, monoclonal; antineoplastic agents; cetuximab; colorectal neoplasms; dna copy number variations; drug resistance, neoplasm; exome; female; genome, human; humans; insulin receptor substrate proteins; map kinase kinase 1; mice; molecular targeted therapy; mutation; proto-oncogene proteins p21; receptor, epidermal growth factor; receptor, erbb-2; receptor, fibroblast growth factor, type 1; receptor, platelet-derived growth factor alpha; xenograft model antitumor assays; genomics; multidisciplinary (1) 1
antibodies, monoclonal - pharmacology (1) 1
antibodies, monoclonal - therapeutic use (1) 1
antigens (1) 1
antigens, cd - physiology (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic agents - therapeutic use (1) 1
antineoplastic agents, alkylating - pharmacology (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
antitumor-activity (1) 1
apoptosis - drug effects (1) 1
ataxia telangiectasia mutated proteins - metabolism (1) 1
biliary tract carcinoma (1) 1
biliary tract neoplasms - blood supply (1) 1
biliary tract neoplasms - drug therapy (1) 1
biliary tract neoplasms - genetics (1) 1
biomarkers (1) 1
biomarkers, tumor (1) 1
blotting, western (1) 1
breast (1) 1
breast cancer (1) 1
breast-cancer (1) 1
breast-cancer cells (1) 1
cancer patients (1) 1
cancer-therapy (1) 1
cd151 (1) 1
cell adhesion (1) 1
cell adhesion - genetics (1) 1
cell culture (1) 1
cell growth (1) 1
cell proliferation - drug effects (1) 1
cell surface receptor (1) 1
cell transformation, neoplastic - genetics (1) 1
cetuximab - pharmacology (1) 1
cetuximab - therapeutic use (1) 1
cholangiocarcinoma (1) 1
cholangiocellular carcinoma (1) 1
cisplatin (1) 1
clinical trials (1) 1
clinical-significance (1) 1
codon (1) 1
codon - genetics (1) 1
colleges & universities (1) 1
colon (1) 1
colorectal neoplasms - pathology (1) 1
combination (1) 1
cytotoxicity (1) 1
database (1) 1
databases as topic (1) 1
digestive system (1) 1
dioxoles - pharmacology (1) 1
disease models, animal (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 6, pp. 738 - 746
Journal Article
Nature, ISSN 0028-0836, 10/2015, Volume 526, Issue 7572, pp. 263 - 267
Colorectal cancer is the third most common cancer worldwide, with 1.2 million patients diagnosed annually. In late-stage colorectal cancer, the most commonly... 
PANITUMUMAB | THERAPY | MULTIDISCIPLINARY SCIENCES | SEQUENCE | ACQUIRED-RESISTANCE | SOMATIC MUTATION | IDENTIFICATION | GENE COPY NUMBER | ACTIVATING MUTATIONS | BREAST | INSIGHTS | Receptor, Epidermal Growth Factor - genetics | Receptor, ErbB-2 - genetics | Proto-Oncogene Proteins p21(ras) - genetics | Colorectal Neoplasms - genetics | Genomics | Humans | Antibodies, Monoclonal - therapeutic use | Antineoplastic Agents - therapeutic use | Cetuximab - therapeutic use | Molecular Targeted Therapy | Receptor, Fibroblast Growth Factor, Type 1 - genetics | MAP Kinase Kinase 1 - genetics | Colorectal Neoplasms - drug therapy | Female | Antineoplastic Agents - pharmacology | Insulin Receptor Substrate Proteins - genetics | Colorectal Neoplasms - metabolism | Antibodies, Monoclonal - pharmacology | Cetuximab - pharmacology | DNA Copy Number Variations - genetics | Mutation - genetics | Genome, Human - genetics | Receptor, Epidermal Growth Factor - chemistry | Xenograft Model Antitumor Assays | Drug Resistance, Neoplasm - genetics | Exome - genetics | Animals | Receptor, Platelet-Derived Growth Factor alpha - genetics | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Mice | Drug Resistance, Neoplasm - drug effects | Care and treatment | Gene mutations | Colorectal cancer | Drug metabolism | Genetic aspects | Identification and classification | Health aspects | Proteins | Epidermal growth factor | Genes | Clinical trials | Mutation | Kinases | Cancer therapies | Tumors
Journal Article
Cancer Research, ISSN 0008-5472, 11/2017, Volume 77, Issue 21, pp. e62 - e66
Patient-derived tumor xenograft (PDX) mouse models have emerged as an important oncology research platform to study tumor evolution, mechanisms of drug... 
DATABASE | ONCOLOGY | PROMISE | Animals | Neoplasms - genetics | Humans | Mice | Xenograft Model Antitumor Assays - statistics & numerical data | Patients | Databases as Topic | Disease Models, Animal | Neoplasms - drug therapy | Medical research | Quality assurance | Animal models | Reproducibility | Quality control | Xenografts | Implantation | Standards | Tumors | Cancer
Journal Article
Molecular Cancer, ISSN 1476-4598, 05/2010, Volume 9, Issue 1, pp. 121 - 121
Journal Article
GENOME MEDICINE, ISSN 1756-994X, 06/2019, Volume 11, Issue 1, pp. 42 - 22
BackgroundNeoantigens that arise as a consequence of tumor-specific mutations can be recognized by T lymphocytes leading to effective immune surveillance. In... 
HUMAN COLON | MUTATIONAL SIGNATURES | DRUG-SENSITIVITY | Immune response | Mutational signature | MICROSATELLITE INSTABILITY | Colorectal cancer | DNA repair | GENOMIC LANDSCAPE | EVOLUTION | GENETICS & HEREDITY | RESISTANCE | GENERATION | EGFR BLOCKADE | Neoantigen | XENOGRAFTS | Antigens | Care and treatment | Cancer patients | Gene mutations | Genetic aspects | Research | Health aspects
Journal Article
BMC Cancer, ISSN 1471-2407, 12/2014, Volume 14, Issue 1, pp. 918 - 918
Journal Article
Neuroimmunomodulation, ISSN 1021-7401, 10/2012, Volume 19, Issue 6, pp. I - IV
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.